Lupin launches generic joint pain drug in US

The company's product -- Diclofenac Sodium Topical Solution 2% -- is the generic version of Horizon Pharma Therapeutics Pennsaid
By PTI on December 12, 2022

Lupin recently said it has launched a generic version of Pennsaid, used to treat pain in the knees caused by osteoarthritis in the American market.

The company’s product — Diclofenac Sodium Topical Solution 2% — is the generic version of Horizon Pharma Therapeutics Pennsaid, a company statement mentioned.

Diclofenac Sodium Topical Solutiongeneric joint pain drugHorizon Pharma TherapeuticsLupinPennsaid
Related Posts

Genpact extends partnership with Ferring Pharmaceuticals to enhance operations

Lupin and NAPCON host Walkathon to raise COPD awareness

Jiangsu Hansoh ADC HS-20093 holds potential to set new standard in SCLC second-line treatment in China: GlobalData

Vyvgart Hytrulo gains first APAC approval in China, redefining CIDP care: GlobalData

Soft launch of first indigenous antibiotic to combat AMR, Nafithromycin, announced by Dr Jitendra Singh

Model N introduces Generative AI and expanded data capabilities in core solutions

360 ONE Asset acquires stake in OneSource
Comments (1)
Add Comment
  • soundos

    Thanks for share this post